Table 1 Baseline characteristics
Parameter | Enlarged supradiaphragmatic lymph nodes | P-value | |
|---|---|---|---|
Present N = 47 | Absent N = 24 | ||
Age, years (mean ± SD) | 62.4 ± 8.7 | 65.7 ± 10.1 | 0.158 |
BRCA status, n (%) | |||
Unknown | 12 (25.6%) | 6 (25%) | 0.714 |
BRCA1 positive | 8 (17%) | 6 (25%) | |
BRCA1 negative | 27 (57.4%) | 12 (50%) | |
CA-125 at diagnosis, U/ml (mean ± SD) | 1797.3 ± 357.5 | 708.2 ± 98.6 | 0.048 |
Surgery, n (%) | |||
Upfront | 22 (46.8%) | 9 (37.5%) | 0.454 |
Interval | 25 (53.2%) | 15 (62.5%) | |
Histology, n (%) | |||
Serous | 43 (91.6%) | 23 (95.8%) | 0.773 |
Endometrioid | 1 (2.1%) | 0 (0%) | |
Mucinous | 1 (2.1%) | 0 (0%) | |
Carcinosarcoma | 1 (2.1%) | 1 (4.2%) | |
Squamous cell | 1 (2.1%) | 0 (0%) | |
Tumor burden* (average Eisenkop score) | 4.4 ± 2.0 | 4.5 ± 2.1 | 0.854 |